30 related articles for article (PubMed ID: 26925786)
1. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.
Parker NR; Hudson AL; Khong P; Parkinson JF; Dwight T; Ikin RJ; Zhu Y; Cheng ZJ; Vafaee F; Chen J; Wheeler HR; Howell VM
Sci Rep; 2016 Mar; 6():22477. PubMed ID: 26940435
[TBL] [Abstract][Full Text] [Related]
3. Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.
Kitchen MO; Bryan RT; Emes RD; Glossop JR; Luscombe C; Cheng KK; Zeegers MP; James ND; Devall AJ; Mein CA; Gommersall L; Fryer AA; Farrell WE
Epigenetics; 2016 Mar; 11(3):237-46. PubMed ID: 26929985
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors.
Bady P; Delorenzi M; Hegi ME
J Mol Diagn; 2016 May; 18(3):350-361. PubMed ID: 26927331
[TBL] [Abstract][Full Text] [Related]
5. Roles of Non-coding RNAs and Angiogenesis in Glioblastoma.
Balandeh E; Mohammadshafie K; Mahmoudi Y; Hossein Pourhanifeh M; Rajabi A; Bahabadi ZR; Mohammadi AH; Rahimian N; Hamblin MR; Mirzaei H
Front Cell Dev Biol; 2021; 9():716462. PubMed ID: 34646821
[TBL] [Abstract][Full Text] [Related]
6. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer.
Hassn Mesrati M; Behrooz AB; Y Abuhamad A; Syahir A
Cells; 2020 May; 9(5):. PubMed ID: 32429463
[TBL] [Abstract][Full Text] [Related]
7. ZSCAN10 promotes cell proliferation, upregulates OCT4 expression, and activates Wnt/β-catenin signaling in glioma.
Jiang Y; Huang H; Zhu X; Wu M; Ye M; Xiao B; Yu C; Fang H; Liu F; Lv S
Int J Clin Exp Pathol; 2019; 12(3):700-710. PubMed ID: 31933877
[TBL] [Abstract][Full Text] [Related]
8. MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma.
Chen X; Yang F; Zhang T; Wang W; Xi W; Li Y; Zhang D; Huo Y; Zhang J; Yang A; Wang T
J Exp Clin Cancer Res; 2019 Feb; 38(1):99. PubMed ID: 30795814
[TBL] [Abstract][Full Text] [Related]
9. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
10. Role of OCT4 in cancer stem-like cells and chemotherapy resistance.
Mohiuddin IS; Wei SJ; Kang MH
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165432. PubMed ID: 30904611
[TBL] [Abstract][Full Text] [Related]
11. OCT4 is up-regulated by DNA hypomethylation of promoter in recurrent gliomas.
Wu Y; Sun B; Shi W; Ni L; Chen J; Cai G; Shi J
Neoplasma; 2016; 63(3):378-84. PubMed ID: 26925786
[TBL] [Abstract][Full Text] [Related]
12. OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas.
Shi J; Shi W; Ni L; Xu X; Su X; Xia L; Xu F; Chen J; Zhu J
Oncol Rep; 2013 Jul; 30(1):201-6. PubMed ID: 23670345
[TBL] [Abstract][Full Text] [Related]
13. Stem cell markers in glioma progression and recurrence.
Hattermann K; Flüh C; Engel D; Mehdorn HM; Synowitz M; Mentlein R; Held-Feindt J
Int J Oncol; 2016 Nov; 49(5):1899-1910. PubMed ID: 27600094
[TBL] [Abstract][Full Text] [Related]
14. DNA hypomethylation of CD133 promoter is associated with recurrent glioma.
Sun B; Wan Z; Shen J; Ni L; Chen J; Cui M; Ni H; Shi W; Shi J
Oncol Rep; 2016 Aug; 36(2):1062-8. PubMed ID: 27374817
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]